StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Trubion Pharmaceuticals Inc

Enter Symbol or Keywords

Third Quarter Cash Flow from Operations Turns Positive for Trubion Pharmaceuticals

Stock Quote: (NGM:TRBN)

11/20/2009

3.86

+0.7118

+22.60%

55,738

Third Quarter Cash Flow from Operations Turns Positive for Trubion Pharmaceuticals

Last

Price Change

% Chg

Volume

New York, NY, November 20, 2009-CFFO-NEWS reports that Cash Flow from Operations (CFFO) for Trubion Pharmaceuticals, Inc. (NASDAQ:TRBN) for its third quarter ended September 30, 2009 was a positive $1 ... read full story

Website Address:	www.trubion.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: TRBN

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: TRBN

11/24/2009

Trubion Pharmaceuticals' EBITDA Hits Three Year Low

11/20/2009

T12-NEWS reports that the Revenue of Trubion Pharmaceuticals for its 12 month ended September 30, 2009 Decreased by -4.71%

11/20/2009

StockDiagnostics.com Upgrades Trubion Pharmaceuticals' OPS Ranking

... more TRBN exclusives

Other News Sources: TRBN

01/11/2010

Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)

01/06/2010

Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at OneMedForum 2010

12/07/2009

Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting

... more TRBN news from other sources

Daily Market Updates

02/09/2010

Markets Close Day After Strong Rally as Concerns Ease re Greece

Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story